Navigation Links
UTHealth studies cord blood stem cells for pediatric traumatic brain injury
Date:1/5/2011

HOUSTON (Jan. 5, 2010) The University of Texas Health Science Center at Houston (UTHealth) has begun enrollment for the first Phase I safety study approved by the Food and Drug Administration to investigate the use of a child's own umbilical cord blood stem cells for traumatic brain injury in children. The study is being performed in conjunction with Children's Memorial Hermann Hospital, UTHealth's primary children's teaching hospital.

The innovative study, which builds on UTHealth's growing portfolio of research using stem cell-based therapies for neurological damage, is led by principal investigator Charles S. Cox, the Children's Fund Distinguished Professor of Pediatric Surgery and Pediatrics at The University of Texas Medical School at Houston, part of UTHealth, and director of the pediatric trauma program at Children's Memorial Hermann Hospital. It will enroll 10 children ages 18 months to 17 years who have umbilical cord blood banked with Cord Blood Registry (CBR) and have suffered moderate to severe traumatic brain injury (TBI).

The study is not designed for acute care and will only enroll participants within 6-18 months of their injury.

Although the neurologic outcome for nearly all types of brain injury (with the exception of abuse) is better for children than adults, trauma is the leading cause of death in children, and the majority of the deaths are attributed to head injury.

"Using cord blood is a critical link in the next step of UTHealth's programmatic approach to researching stem cell therapies for brain injury," Cox said. "Implementing this novel therapy has required strong partnerships with Children's Memorial Hermann Hospital and the CBR Center for Regenerative Medicine, and is possible through a critical infrastructure investment by the state of Texas and private philanthropy."

To enroll in the study, parents or caregivers of patients who have suffered a traumatic brain injury should contact CBR (www.cordblood.com/UTHealth) and after consent is obtained, the information will be relayed to the UTHealth research group. If all qualifications are met, the patient will travel to Children's Memorial Hermann Hospital. The cells will be processed and intravenously infused. Patients will be followed at six months, one year and two years.

A recently completed Phase I study at UTHealth (publication in press), which investigated a bone-marrow stem cell therapy in children with acute traumatic brain injury, revealed positive safety results, Cox said. The FDA-authorized protocol is specific to the standardized processing and storage protocol of CBR, making it the only family stem cell bank providing patients for the study.

"This study is at the forefront of research evaluating a child's own cord blood stem cells' ability to help facilitate the healing process after damage to nerve tissue in the brain," said Heather Brown, vice president of scientific & medical affairs at Cord Blood Registry. "CBR is helping advance medical research for regenerative therapies by connecting the child whose family banked with CBR to appropriate researchers."

UTHealth is also investigating stem cell therapy for acute stroke patients in an NIH-sponsored, Phase I study by Sean Savitz, M.D., associate professor in the Department of Neurology; and for acute myocardial infarction (heart attack) patients in a Phase II study led by Ali E. Denktas, M.D., assistant professor in the Department of Internal Medicine.


'/>"/>

Contact: Deborah Mann Lake
deborah.m.lake@uth.tmc.edu
University of Texas Health Science Center at Houston
Source:Eurekalert

Related biology news :

1. Community involvement important in fight against childhood obesity, according to UTHealth researchers
2. UTHealth stem cell scientists explore treatments for blood disorders and lung diseases
3. UTHealth neuroscientist wins prominent NIH Directors Pioneer Award
4. UTHealth, BioHouston sign collaborative agreement
5. UTHealth discoveries shed more light on deadly thoracic aortic disease
6. UTHealth School of Biomedical Informatics professor to be inducted to AIMBE College of Fellows
7. UTHealth professor to receive service award from American Society for Microbiology
8. New studies find global warming will have significant economic impacts on Florida coasts
9. NIHs Genes, Environment and Health Initiative adds 6 studies
10. 6 environmental research studies reveal critical health risks from plastic
11. NIAID funds studies of how SARS and bird flu evade antiviral responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2016)... , March 9, 2016 ... identified that more than 23,000 public service employees either ... been receiving their salary unlawfully.    --> ... government identified that more than 23,000 public service employees ... had been receiving their salary unlawfully.    --> ...
(Date:3/3/2016)... MONTEREY, Calif. , March 3, 2016  FlexTech, ... in the categories of Innovation, Research & Development, Leadership ... Industry Leadership. This is the 9 th year ... select group of companies and individuals from past ... nominations based on a pre-described set of criteria, by ...
(Date:3/2/2016)... , March 2, 2016 ... the addition of the  "Global Biometrics Market ... offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , Global ... grow at a CAGR of around 27% ... ) has announced the addition of the  ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... Italy , April 29, 2016 ... 5.11, the latest update to its industry-leading treatment planning ... shown that Monaco version 5.11 ... can now attain calculation speeds up to four times ... . With the industry,s gold standard ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... Connecticut's innovative, growing companies, today announced the launch of VentureClash , a ... companies. , “VentureClash looks to attract the best early-stage companies here ...
(Date:4/28/2016)... Connecticut (PRWEB) , ... April 28, 2016 , ... ... Group, Inc., will hold an open house for regional manufacturers at its Maple ... displays from Tsugami, Okuma, Hardinge Group, Chiron and Trumpf. Almost 20 leading ...
(Date:4/27/2016)... ... ... The Pittcon Organizing Committee is pleased to announce that Charles “Chuck” Gardner was named ... 1987. Since then, he has served in a number of key leadership positions including ... program and exposition committees. In his professional career, Dr. Gardner is the director of ...
Breaking Biology Technology: